# INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Unicycive Therapeutics, Inc. to Contact Law Firm

- Source: PR Newswire
- Published: 2026-10-20T20:17:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/investor-action-notice-moore-law-pllc-encourages-investors-in-unicycive-therapeutics-inc-to-contact-law-firm-302914521.html
- Canonical: https://groundlevelnews.com/story/investor-action-notice-moore-law-pllc-encourages-investors-in-unicyciv-2ea7f6/

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shareholders should email fletcher@fmoorelaw.com NEW YORK, Oct. 20, 2026 /PRNewswire/ -- What is the Investigation About? On June 30, 2026, before the market opened, Unicycive disclosed that the FDA had issued a second Complete Response Letter...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._